Animal Model of Uterine Adenomyosis: Induction of the Lesion in Rats by Ectopic Pituitary Isografting

Laboratory Animal Science

Volumn 48, Issue 1, 1998, Pages 64-68

  Mori, Takao ^a   Kyokuwa, Miho ^a   Nagasawa, Hiroshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MEIJI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOHYPOPHYSIS; ANIMAL; ARTICLE; DISEASE MODEL; ELECTRON MICROSCOPY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HETEROTOPIC TRANSPLANTATION; MALE; MYOMETRIUM; OVARY; PATHOLOGY; RAT; TRANSPLANTATION; ULTRASTRUCTURE; UTERUS; UTERUS DISEASE; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; MALE; MICROSCOPY, ELECTRON; MYOMETRIUM; OVARY; PITUITARY GLAND, ANTERIOR; RATS; RATS, WISTAR; TRANSPLANTATION, HETEROTOPIC; UTERINE DISEASES; UTERUS;

EID: 0031990989     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Emge, L. A. 1962. The elusive adenomyosis of the uterus: its historical past and its present state of recognition. Am. J. Obstet. Gynecol. 83:1541-1563.
2. Mody, J. K. 1963. Structural changes in the ovaries of IF mice due to age and various other states: demonstration of grouped virgins. Anat. Rec. 145:439-447.
3. Frith, C. H., B. Highman, G. Burger, et al. 1983. Spontaneous lesions in virgin and retired breeder BALB/c and C57BL/6 mice. Lab. Anim. Sci. 33:273-286.
4. Mori, T., and H. Nagasawa. 1984. Alteration of the development of mammary hyperplastic alveolar nodules and uterine adenomyosis in SHN mice by different schedules of treatment with CB-154. Acta Endocrinol. 107:245-249.
5. Mor, N., and I. Lutsky. 1986. Spontaneous endometrial tumors of 'Sabra' rats. Lab. Animals 20:316-320.
6. Mori, T., and H. Nagasawa. 1989. Multiple endocrine syndrome in SHN mice: mammary tumors and uterine adenomyosis, p. 121-130. In H. E. Kaiser (ed.), Comparative aspects of tumor development. Kluwer, Dordrecht, The Netherlands.
7. Mori, T., H. Nagasawa, and Y. Ohta. 1989. Prolactin and uterine adenomyosis in mice, p. 123-139. In H. Nagasawa (ed.), Prolactin and lesions in breast, uterus and prostate. CRC Press, Boca Raton, Fla.
8. Lacassagne, A. 1935. Modification progressive de l'uterus de la souris sous l'action prolongee de l'oestrone. C. R. Sean. Soc. Biol. 120:1156-1158.
9. Loeb, L., E. L. Burns, V. Suntzeff, et al. 1936. Carcinomalike proliferation in the vagina, cervix and uterus of a mouse treated with estrogenic hormones. Proc. Soc. Exp. Biol. Med. 35:320-322.
10. Nelson, W. O. 1937. Endometrial and myometrial changes, including fibromatous nodules, induced in the uterus of guinea pig by prolonged administration of oestrogenic hormone. Anat. Rec. 68:99-102.
11. Pan, S. C., and W. U. Gardner. 1948. Carcinomas of the uterine cervix and vagina in estrogen- and androgen-treated hybrid mice. Cancer Res. 8:337-341.
12. Crossen, R. J., and V. Suntzeff. 1950. Endometrial polyps and hyperplasia produced in an aged monkey with estrogen plus progesterone. Arch. Pathol. 50:721-726.
13. Meissner, W. A., S. C. Sommers, and G. Sherman. 1957. Endometrial hyperplasia, endometrial carcinoma, and endometriosis produced experimentally by oestrogen. Cancer 10:500-509.
14. Lipschutz, A., R. Iglesias, V. I. Panasevich, et al. 1967. Pathological changes induced in the uterus of mice with the prolonged administration of progesterone and 19-nor-contraceptives. Br. J. Cancer 21:160-165.
15. MacKenzie, W. F., and H. W. Casey. 1975. Animal model: endometriosis in rhesus monkeys. Am. J. Pathol. 80:341-344.
16. Mori, T., H. Nagasawa, and S. Takahashi. 1981. The induction of adenomyosis in mice by intrauterine pituitary isografts. Life Sci. 29:1277-1282.
17. Mori, T., H. Nagasawa, and Y. Nakajima. 1982. Straindifference in the induction of adenomyosis by intrauterine pituitary grafting in mice. Lab. Anim. Sci. 32:40-41.
18. Mori, T., T. Singtripop, and S. Kawashima. 1991. Animal model of uterine adenomyosis: is prolactin a potent inducer of adenomyosis in mice? Am. J. Obstet. Gynecol. 165:232-234.
19. Huseby, R. A., and S. Thurlow. 1982. Effects of prenatal exposure of mice to "low-dose" diethylstilbestrol and the development of adenomyosis associated with evidence of hyperprolactinemia. Am. J. Obstet. Gynecol. 144:939-949.
20. Huseby, R. A., M. J. Soares, and F. Talamantes. 1985. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Endocrinology 116:1440-1448.
21. TeLinde, R. W., and R. B. Scott. 1950. Experimental endometriosis. Am. J. Obstet. Gynecol. 60:1147-1173.
22. Jones, R. C. 1984. The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat. Acta Endocrinol. 106:282-288.
23. Sakata, M., N. Terakawa, T. Mizutani, et al. 1990. Effects of danazol, gonadotropin-releasing hormone agonists, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis. Am. J. Obstet. Gynecol. 163:1679-1684.
24. Nagasawa, H., and R. Yanai. 1978. Mammary gland prolactin receptor and pituitary prolactin secretion in lactating mice with different lactational performance. Acta Endocrinol. 88:94-98.
25. Nagasawa, H., and R. Yanai. 1981. The in vitro mammary gland response to mammotropic hormones in mice with different mammary tumorigenesis. Eur. J. Cancer 17:503-509.
26. Mori, T., Y. Ohta, and H. Nagasawa. 1984. Ultrastructural changes in uterine myometrium of mice with experimentally-induced adenomyosis. Experientia 40:1385-1387.
27. Ohta, Y., T. Mori, and H. Nagasawa. 1985. Ultrastructural changes of endometrium and myometrium during development of adenomyosis in mice with ectopic pituitary transplants. Zool. Sci. 2:239-247.
28. Ostrander, P. L., K. T. Mills, and H.A. Bern. 1985. Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure. J. Natl. Cancer Inst. 74:121-135.
29. Singtripop, T., T. Mori, and K. Shiraishi, et al. 1993. Age-related changes in gonadotropin, prolactin and growth hormone levels with reference to the development of uterine adenomyosis in female SHN mice. In Vivo 7:147-150.
30. Matsuda, M., T. Mori, M. K. Park, et al. 1994. Enhanced cell proliferation by hyperprolactinemia in both exocrine and endocrine pancreas in mice. Eur. J. Endocrinol. 130:187-194.
31. Yamashita, M., M. Matsuda, and T. Mori. 1997. Increased expression of prolactin receptor mRNA in adenomyotic uterus in mice. Life Sci. 17:1437-1446.
32. Nagasawa, H., M. Ishida, and T. Mori. 1987. Effects of treatment with prolactin or progesterone on the coincidence of mammary tumors and uterine adenomyosis in young SHN mice. Lab. Anim. Sci. 37:200-202.
33. Yamashita, M., and T. Mori. 1997. Disturbed cell arrangement, increased cell membrane permeability and apoptotic cell death occur in adenomyotic uterine tissues in mice. Zool. Sci. 14:659-664.
34. Russel, D. H. 1989. New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol. 10:40-44.
35. Kelly, P. A., J. Djiane, M. C. Postel-Vinary, et al. 1991. The prolactin/growth hormone receptor family. Endocrinol. Rev. 12:235-251.